BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer

The X-Cancer's investigator-led trial of SAR-bisPSMA in known or suspected prostate cancer (X-Calibur) is a Phase I/II IIT in up to 150 patients at the Uro...

March 25, 2022 | News

RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics

Under the agreement, both companies will collaborate to develop next-generation mRNA-based antibody therapeutics by utilizing the proprietary mRNA platform...

March 22, 2022 | News

BioVaxys Announces Bioproduction of BVX-1021

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), today announced that it has entered into an agreem...

March 21, 2022 | News

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership

Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...

March 18, 2022 | News

Everest Medicines to further enhance its international commercial footprint

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...

March 14, 2022 | News

Suvoda Unveils New Brand to Reflect Expanded Focus in Complex Clinical Trial Management

Suvoda LLC today launched a refreshed brand, to better reflect its leadership position as a global clinical trial technology company that specia...

March 09, 2022 | News

Veristat Expands its Expertise and Scale across Biopharma and Medtech

Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...

March 08, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

March 03, 2022 | News

PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial

The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...

February 28, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...

February 21, 2022 | News

Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...

February 18, 2022 | News

Biotium announces optimised antibody labeling kits for super-resolution microscopy

Biotium, a supplier of cutting-edge life science reagents, is expanding their line of industry-leading Mix-n-Stain™ labeling kits with new kits desig...

February 16, 2022 | News

Kintor Pharma Announces First Patient Dosing in China

Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...

February 14, 2022 | News

GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability

The state-of-the-art site marks a significant expansion of the company's advanced protein and gene platforms, and is designed to provide high quality...

February 10, 2022 | News

Stay Connected